• Mashup Score: 0

    The voted to warn against relying on its “outdated” previous advocacy statement and studies about the PBM industry.

    Tweet Tweets with this article
    • More pressure on #PBMs. This will not stop from the ⁦@FTC⁩ Congress & state legislatures. Doesn’t happen overnight but the tide is turning. https://t.co/83pidRxaU6

  • Mashup Score: 5

    Business Before the Commission: Statement Withdrawing Prior PBM Advocacy and Staff Presentation on Military Consumer Protection Efforts

    Tweet Tweets with this article
    • Dr Prowell is spot on! #PBMAbuse must end. Along w/ recently introduced federal legislation to address issues, on July 20 the @FTC continues their probe into #PBM practices. You can submit your comments through 8 pm ET on July 18👇 https://t.co/3WjBK0L9ke #PBMs #OncTwitter https://t.co/kuM4tHAqCG https://t.co/icEmcSsCXK

  • Mashup Score: 1

    A coalition that includes patient advocacy groups and the Iowa Pharmacy Association is launching what they’re calling an “accountability project” focused on Pharmacy Benefit Managers. Pharmacy Benefit Managers or PBMs are companies that manage prescription drug benefit plans for insurance companies and Medicare Part D as well as large companies. “They’re the ones in the […]

    Tweet Tweets with this article
    • This should happen in every state. Put together coalitions to stop #PBM abuses. Top #PBMs must go! https://t.co/pD7JRKclAf

  • Mashup Score: 0

    The shift follows the COVID-19 pandemic, when Congress poured $178 billion into helping hospitals offset financial losses and care for more patients.

    Tweet Tweets with this article
    • It's about time these large health systems face the music of transparency. They hate the light as mush as the #PBMs. And they are dragging down out true community hospitals, especially those struggling in rural areas. https://t.co/ipSsyfb0oT

  • Mashup Score: 2

    The trade group representing the nation’s top pharmacy benefit managers is redoubling criticism of congressional scrutiny into the industry, taking aim at a House panel for not inviting the organization’s members to testify in a hearing Tuesday.

    Tweet Tweets with this article
    • The “poor” #PBMs crying foul that they weren’t invited to testify. I would be careful what you ask for because your time will come. So tired of #PBM abuses that get in the way of #cancer patients getting the right treatment at the right time. https://t.co/xwabnXzGTJ